[The efficacy of oxyferriscorbone in peptic ulcer].
Zaiachuk
V M
VM
Neĭko
E M
EM
Denisiuk
V G
VG
Parashchak
A P
AP
Kosiakova
M P
MP
Debenko
M M
MM
D015083:2,3-Diketogulonic Acid / Q000627:therapeutic use*; D000328:Adult; D000496:Alloxan / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004338:Drug Combinations; D004341:Drug Evaluation; D004361:Drug Tolerance; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000378:metabolism; D004384:Duodenoscopy; D005290:Ferric Compounds / Q000627:therapeutic use*; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008875:Middle Aged
D000897:Anti-Ulcer Agents; D004338:Drug Combinations; D005290:Ferric Compounds; D015083:2,3-Diketogulonic Acid; C008747:oxyferriscorbone; D000496:Alloxan
Effektivnost' oksiferriskorbona pri iazvennoĭ bolezni.